A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Clinical trial NCT06675929 · COMPLETED

Trial details

NCT number: NCT06675929
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Compensated Liver Cirrhosis Metabolic Dysfunction Associated Steatohepatitis (MASH)

Start date: 2025-01-20
Primary completion: 2026-01-13
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.